(Q53399960)

13 May 2018

title

Elevated survivin is associated with a poor response to chemotherapy and reduced survival in lung cancer with malignant pleural effusions. (English)

1 reference

13 May 2018

author name string

Do-Sim Park

1

1 reference

13 May 2018

Ki-Eun Hwang

2

1 reference

13 May 2018

Hyeok Shim

3

1 reference

13 May 2018

Byoung-Ryun Kim

4

1 reference

13 May 2018

Keum-Ha Choi

5

1 reference

13 May 2018

Seong-Hoon Park

6

1 reference

13 May 2018

Seok-Don Park

7

1 reference

13 May 2018

Eun-Taik Jeong

8

1 reference

13 May 2018

Hak-Ryul Kim

9

1 reference

13 May 2018

publication date

2 November 2011

1 reference

13 May 2018

Clinical & Experimental Metastasis

published in

1 reference

13 May 2018

volume

29

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

83-89

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1007/s10585-011-9431-7

exact match

0 references

cites work

Malignant effusions: Diagnostic evaluation and therapeutic strategy

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

Diagnostic utility of pleural fluid carcinoembryonic antigen and CYFRA 21-1 in patients with pleural effusion: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

IAP family protein expression correlates with poor outcome of multiple myeloma patients in association with chemotherapy-induced overexpression of multidrug resistance genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

Survivin: a promising tumor biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

Survivin, cancer networks and pathway-directed drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

Quantitative detection of survivin in malignant pleural effusion for the diagnosis and prognosis of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

The IASLC Lung Cancer Staging Project: proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

Revisions in the International System for Staging Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

Expression of the anti-apoptotic gene survivin correlates with taxol resistance in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

Survivin gene expression in early-stage non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-011-9431-7

Diagnostic principles in pleural disease

21 January 2018

1 reference

12 December 2020

Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.

1 reference

12 December 2020

The inhibitors of apoptosis (IAPs) and their emerging role in cancer

1 reference

12 December 2020

Emmprin and Survivin Predict Response and Survival following Cisplatin-Containing Chemotherapy in Patients with Advanced Bladder Cancer

1 reference

12 December 2020

The treatment of malignant pleural effusions

1 reference

12 December 2020

Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.

1 reference

12 December 2020

Improving tumor cell detection in pleural effusions by interphase cytogenetics

1 reference

12 December 2020

Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions

1 reference

12 December 2020

Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions

1 reference

12 December 2020

Serum levels of HMGB1, survivin, and VEGF in patients with advanced non-small cell lung cancer during chemotherapy

1 reference

12 December 2020

Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas

1 reference

12 December 2020

Expression of survivin and of antigen detected by a novel monoclonal antibody, T332, is associated with outcome of diffuse large B-cell lymphoma and its subtypes

1 reference

12 December 2020

Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer

1 reference

12 December 2020

10.1007/S10585-011-9431-7

Identifiers

DOI

1 reference

13 May 2018

release_i3iimlg2u5da3bhfw2vyve2dl4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i3iimlg2u5da3bhfw2vyve2dl4

24 November 2022

mapped directly with Wikidata item

1 reference

13 May 2018